ZA200201828B - Pharmaceutical solutions of levosimendan. - Google Patents

Pharmaceutical solutions of levosimendan.

Info

Publication number
ZA200201828B
ZA200201828B ZA200201828A ZA200201828A ZA200201828B ZA 200201828 B ZA200201828 B ZA 200201828B ZA 200201828 A ZA200201828 A ZA 200201828A ZA 200201828 A ZA200201828 A ZA 200201828A ZA 200201828 B ZA200201828 B ZA 200201828B
Authority
ZA
South Africa
Prior art keywords
levosimendan
pharmaceutical solutions
pharmaceutical
solutions
Prior art date
Application number
ZA200201828A
Other languages
English (en)
Inventor
Reijo Baeckstroem
Ritva Haikala
Eva Saukko
Paeivi Granvik
Sirpa Pelttari
Reija Yrjoelae
Original Assignee
Orion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8555263&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200201828(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Orion Corp filed Critical Orion Corp
Publication of ZA200201828B publication Critical patent/ZA200201828B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ZA200201828A 1999-09-10 2002-03-05 Pharmaceutical solutions of levosimendan. ZA200201828B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI991925A FI109659B (fi) 1999-09-10 1999-09-10 Levosimendaanin farmaseuttisia liuoksia

Publications (1)

Publication Number Publication Date
ZA200201828B true ZA200201828B (en) 2003-08-27

Family

ID=8555263

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200201828A ZA200201828B (en) 1999-09-10 2002-03-05 Pharmaceutical solutions of levosimendan.

Country Status (39)

Country Link
US (2) US6730673B1 (fr)
EP (1) EP1210085B1 (fr)
JP (1) JP4708648B2 (fr)
KR (1) KR100869752B1 (fr)
CN (1) CN1203855C (fr)
AR (1) AR025449A1 (fr)
AT (1) ATE315937T1 (fr)
AU (1) AU771027B2 (fr)
BG (1) BG65827B1 (fr)
BR (1) BRPI0013924B8 (fr)
CA (1) CA2382013C (fr)
CO (1) CO5180582A1 (fr)
CZ (1) CZ303095B6 (fr)
DE (1) DE60025627T2 (fr)
DK (1) DK1210085T3 (fr)
EA (1) EA005067B1 (fr)
EE (1) EE05375B1 (fr)
ES (1) ES2256034T3 (fr)
FI (1) FI109659B (fr)
HK (1) HK1049282B (fr)
HR (1) HRP20020298B1 (fr)
HU (1) HU228340B1 (fr)
IL (2) IL148379A0 (fr)
IS (1) IS2244B (fr)
ME (1) ME00523B (fr)
MX (1) MXPA02002423A (fr)
MY (1) MY125984A (fr)
NO (1) NO331989B1 (fr)
NZ (1) NZ517605A (fr)
PL (1) PL202356B1 (fr)
PT (1) PT1210085E (fr)
RS (1) RS50445B (fr)
SI (1) SI1210085T1 (fr)
SK (1) SK287154B6 (fr)
TR (1) TR200200620T2 (fr)
TW (1) TWI242434B (fr)
UA (1) UA73954C2 (fr)
WO (1) WO2001019334A2 (fr)
ZA (1) ZA200201828B (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI109659B (fi) * 1999-09-10 2002-09-30 Orion Yhtymae Oyj Levosimendaanin farmaseuttisia liuoksia
FI20010233A0 (fi) * 2001-02-08 2001-02-08 Orion Corp Menetelmä sydämen vajaatoiminnan hoitoon
CN100428937C (zh) * 2003-10-30 2008-10-29 北京海合天科技开发有限公司 左西孟旦冷冻干燥组合物
CN100367964C (zh) * 2004-04-29 2008-02-13 王思清 左西孟旦-β环糊精包含物制剂
WO2006087419A2 (fr) * 2005-02-18 2006-08-24 Orion Corporation Methode d'administration de levosimendan
WO2008082871A1 (fr) * 2006-12-28 2008-07-10 Orion Corporation Formulations de levosimendan pour administration parentale
WO2012093404A2 (fr) 2011-01-03 2012-07-12 Gufic Biosciences Limited Formulations parentérales de lévosimendane
US9597425B2 (en) * 2011-10-18 2017-03-21 St. Teresa Medical, Inc. Method of forming a hemostatic product
AU2013262438B2 (en) * 2012-05-18 2017-03-16 Luoda Pharma Limited Liquid formulation
CN105106113B (zh) * 2015-09-30 2019-07-26 济南康和医药科技有限公司 一种左西孟旦注射液及其制备方法
ES2782106T3 (es) * 2015-11-06 2020-09-10 Carinopharm Gmbh Formulaciones mejoradas de levosimendán para administración intravenosa como infusión o inyección y como concentrado de infusión
US10828387B2 (en) 2015-11-12 2020-11-10 St. Teresa Medical, Inc. Method of sealing a durotomy
CN108261398A (zh) * 2016-12-30 2018-07-10 齐鲁制药有限公司 一种含有左西孟旦的供注射用药物制剂及其制备方法
US10953128B2 (en) 2017-11-02 2021-03-23 St. Teresa Medical, Inc. Fibrin sealant products
CN111474289A (zh) * 2019-10-31 2020-07-31 武汉嘉诺康医药技术有限公司 一种利用反相色谱分离分析左西孟旦中右西孟旦的方法
AU2020408323A1 (en) 2019-12-16 2022-08-11 Tenax Therapeutics, Inc. Levosimendan for treating pulmonary hypertension with heart failure with preserved ejection fraction (PH-HF-pEF)
CN111514147B (zh) * 2020-05-12 2021-09-17 成都欣捷高新技术开发股份有限公司 用于急性失代偿心力衰竭症状的左西孟旦钠药用组合物及制备方法
US11760730B2 (en) * 2021-01-11 2023-09-19 Navinta, Llc Process for the preparation of high purity Levosimendan
WO2023027670A2 (fr) * 2021-08-23 2023-03-02 Tum Ekip Ilac Anonim Sirketi Compositions de lévosimendan lyophilisées
CN115518037A (zh) * 2022-10-14 2022-12-27 上药东英（江苏）药业有限公司 一种安全质量稳定的左西孟旦注射剂组合物及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2251615B (en) 1991-01-03 1995-02-08 Orion Yhtymae Oy (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]pro panedinitrile
GB2266841A (en) 1992-05-06 1993-11-17 Orion Yhtymae Oy Compounds for use as anti-ischemic medicaments
GB9606474D0 (en) 1996-03-27 1996-06-05 Orion Yhytmo Oy Method for obtaining pure enantiomers of a pyridazinone derivative
GB9614098D0 (en) * 1996-07-05 1996-09-04 Orion Yhtymae Oy Transdermal delivery of levosimendan
FI980902A (fi) * 1998-04-23 1999-10-24 Orion Yhtymae Oyj Levosimendaanin stabiileja koostumuksia
FI109659B (fi) * 1999-09-10 2002-09-30 Orion Yhtymae Oyj Levosimendaanin farmaseuttisia liuoksia

Also Published As

Publication number Publication date
CA2382013A1 (fr) 2001-03-22
EA005067B1 (ru) 2004-10-28
PT1210085E (pt) 2006-05-31
PL202356B1 (pl) 2009-06-30
SK3272002A3 (en) 2002-12-03
JP4708648B2 (ja) 2011-06-22
CZ303095B6 (cs) 2012-03-28
BRPI0013924B8 (pt) 2021-05-25
NO20021090L (no) 2002-03-05
YU16902A (sh) 2004-09-03
EE05375B1 (et) 2011-02-15
IS6296A (is) 2002-03-06
CN1373665A (zh) 2002-10-09
CA2382013C (fr) 2009-08-11
SI1210085T1 (sl) 2006-04-30
NO331989B1 (no) 2012-05-21
WO2001019334A3 (fr) 2001-11-15
NZ517605A (en) 2003-08-29
EP1210085A2 (fr) 2002-06-05
PL354028A1 (en) 2003-12-15
CO5180582A1 (es) 2002-07-30
IL148379A (en) 2006-12-10
EE200200129A (et) 2003-04-15
HK1049282A1 (en) 2003-05-09
EA200200348A1 (ru) 2002-08-29
AU7004400A (en) 2001-04-17
BG65827B1 (bg) 2010-02-26
AR025449A1 (es) 2002-11-27
CN1203855C (zh) 2005-06-01
US20040106617A1 (en) 2004-06-03
NO20021090D0 (no) 2002-03-05
DE60025627T2 (de) 2006-11-16
HK1049282B (zh) 2005-12-30
KR100869752B1 (ko) 2008-11-21
DE60025627D1 (de) 2006-04-06
HU228340B1 (en) 2013-03-28
FI109659B (fi) 2002-09-30
ATE315937T1 (de) 2006-02-15
FI19991925A (fi) 2001-03-10
EP1210085B1 (fr) 2006-01-18
BG106589A (bg) 2002-11-29
HUP0202749A2 (hu) 2003-02-28
IL148379A0 (en) 2002-09-12
KR20020048400A (ko) 2002-06-22
ME00523B (me) 2011-10-10
RS50445B (sr) 2010-03-02
DK1210085T3 (da) 2006-05-08
AU771027B2 (en) 2004-03-11
TR200200620T2 (tr) 2002-09-23
MY125984A (en) 2006-09-29
HRP20020298B1 (en) 2007-02-28
US6730673B1 (en) 2004-05-04
IS2244B (is) 2007-05-15
BR0013924A (pt) 2002-05-21
CZ2002788A3 (cs) 2002-11-13
HUP0202749A3 (en) 2003-03-28
HRP20020298A2 (en) 2003-06-30
MXPA02002423A (es) 2002-08-12
SK287154B6 (sk) 2010-01-07
US6943164B2 (en) 2005-09-13
BR0013924B1 (pt) 2013-09-24
UA73954C2 (uk) 2005-10-17
WO2001019334A2 (fr) 2001-03-22
JP2003509351A (ja) 2003-03-11
ES2256034T3 (es) 2006-07-16
TWI242434B (en) 2005-11-01

Similar Documents

Publication Publication Date Title
ZA200000894B (en) 4-Phenyl-pyridine derivatives.
HK1051037A1 (en) Benzodiazepine derivatives.
ZA200201055B (en) Amino-triazolopyridine derivatives.
ZA200202544B (en) Benzodiazepine derivatives.
MXPA01013362A (es) Anticuerpos de humano, anti-alfavbeta3 recombinantes, °cidos nucleicos que codifican a los mismos y metodos de uso.
HK1045650A1 (en) Pharmaceutical composition.
HK1049282A1 (en) Pharmaceutical solutions of levosimendan.
ZA200200477B (en) 2-pyrazolin-5-ones.
HK1054384A1 (en) 4-Pyrimidinyl-n-acyl-l-phenylalanines.
ZA200109595B (en) 13-methyl-erythromycin derivatives.
ZA200202537B (en) Pour-on-formulations.
HK1051199A1 (en) New phenylpiperazines.
ZA200104280B (en) Pharmaceutical combination preparations.
HK1046411A1 (en) 5-Phenyl-pyrimidine derivatives.
ZA200203762B (en) 4-pyridinyl-IN-acyl-L-phenylalanines.
ZA200203707B (en) Pharmaceutical combinations.
ZA200201276B (en) 3-Amino-2-phenyl-propane derivatives.
ZA200110454B (en) Pharmaceutical complex.
MXPA01011285A (es) Derivados de tio-oxindol.
HK1046133A1 (en) Pharmaceutical compounds.
ZA200109120B (en) Use of Arylalkanoylpyridazines.
GC0000150A (en) Pharmaceutical solutions of levosimendan.
ZA200108116B (en) Drinkable pharmaceutical solution.
ZA200109481B (en) Cinnamoylaminoalkyl-substituted benzenesulfonamide derivatives.
ZA200204581B (en) Nitro-sulfobenzamides.